Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Primary Care
•
General Primary Care
How, if at all, have the new IDSA guidelines on UTIs changed your perspective on triaging and/or treating UTIs in your practice?
https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/
Related Questions
How do you decide when to use acid-suppressive medications for GI prophylaxis when patients are on prolonged corticosteroid therapy?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?
Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?
Do you routinely adjust your interpretation of SLUMS and/or MOCA tests in patients depending on their level of education?
How do you approach patients who request general"hormone testing" without any medical reason to do so?
Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?
Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?
What is your approach to a situation where DILI is suspected secondary to an important medication (e.g., anticoagulation, antibiotics, etc.), but the diagnosis is uncertain and the liver injury is relatively mild?
How do you approach patients who are inappropriately worried/fixated on a test result that is flagged as abnormal but not clinically significant?
Is there an age cutoff where you consider the risks of monoclonal antibody therapy outweigh any potential benefit(s) in early-onset dementia?
